Saridon Triple Action should not be used if any of the following conditions is present: Allergy to pyrazolones or related compounds (hypersensitivity to phenazone, propyphenazone, aminophenazone, metamizole-containing products); Allergy to phenylbutazone-containing products; Known hypersensitivity to paracetamol, acetylsalicylic acid or proven allergy to caffeine; Inherited deficiency of glucose-6-phosphate dehydrogenase (evidenced by hemolytic anemia); Acute hepatic porphyria.
Special caution should be taken (lowering of the dosage and/or spacing out of the doses) in the following conditions: Impaired hepatic function (e.g. in cases of chronic alcohol abuse or hepatitis); Impaired renal function; Gilbert's syndrome (fluctuating benign jaundice secondary to glucuronyl-transferase deficiency); Hematopoietic dysfunction.
Saridon Triple Action should not be given to infants or children under 12 years of age.
Use in Pregnancy & Lactation: Category C.
It is recommended that Saridon Triple Action should not be used during pregnancy, particularly in the first trimester and in the final six weeks.
Saridon Triple Action should not be used by nursing women.